La Canada Ventures, Inc. v. MDalgorithms, Inc.

CourtDistrict Court, N.D. California
DecidedJanuary 3, 2024
Docket3:22-cv-07197
StatusUnknown

This text of La Canada Ventures, Inc. v. MDalgorithms, Inc. (La Canada Ventures, Inc. v. MDalgorithms, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
La Canada Ventures, Inc. v. MDalgorithms, Inc., (N.D. Cal. 2024).

Opinion

1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 LA CANADA VENTURES, INC., 10 Case No. 22-cv-07197-RS Plaintiff, 11 v. ORDER DENYING PLAINTIFF’S 12 MOTION TO DISMISS MDALGORITHMS, INC., COUNTERCLAIMS AND DENYING 13 PLAINTIFF’S MOTION FOR PARTIAL Defendant. SUMMARY JUDGMENT 14

15 I. INTRODUCTION 16 This is a trademark infringement suit. Plaintiff and Counter-defendant is La Canada 17 Ventures, Inc., a health and beauty retailer offering cosmetic products (“Plaintiff”). Defendant and 18 Counter-claimant MDalgorithms is a company that offers computer software and app technology 19 for education and advice about the treatment of acne, a skin disorder (“Defendant”). In its Second 20 Amended Complaint (“SAC”) Plaintiff avers that Defendant infringes on Plaintiff’s MD Mark and 21 multiple MD-formative Marks by using the MD marks in the sale of its health and beauty 22 products, in direct competition with Plaintiff. Defendant filed counterclaims in a First Amended 23 Counterclaim (“FACC”), seeking cancellation of Plaintiff’s registrations on the grounds that they 24 are void ab initio or otherwise derived the right of incontestability by fraud on the United States 25 Patent and Trademark Office (“USPTO”). Defendant also filed unfair competition counterclaims 26 against Plaintiff, arguing that Plaintiff used Defendant’s marks “MDhair” and “MDacne” 27 unlawfully. Plaintiff now moves for dismissal of Defendant’s counterclaims, claiming that it, not 1 the Defendant, was the first user of the “MD” and related marks and its registrations should not be 2 cancelled. Plaintiff also moves for summary judgment on its trademark infringement claims as to 3 Defendant’s “MDhair” mark. 4 II. BACKGROUND 5 Plaintiff began offering health and beauty products in 2006 under its MD brand, which was 6 founded by Dr. Susan Lin. Plaintiff’s MD brand consists of a family of marks utilizing the term 7 “MD” and multiple other marks, with the root MD in combination with other terms (the “MD- 8 formative Marks”). The “MD “mark is the subject of a federal registration with the United States 9 Patent & Trademark Office (“USPTO”) in Class 3 (cosmetic and cleaning preparations) and Class 10 5 (pharmaceuticals) based on a first use of at least as early as January 1, 2012. Lin also registered 11 multiple MD-formative Marks1 with the USPTO, claiming these marks have been in use since as 12 early as August 1, 2007. Finally, Lin claims that it has adopted and used other unregistered MD- 13 formative Marks since as early as 2006 (MD Skin), 2009 (MD Nutri Hair), and 2018 (MD 14 Wellness). On January 15, 2019, Lin entered into an exclusive, written trademark license 15 agreement with Plaintiff (“January 2019 License Agreement”), before assigning her rights and 16 interests in her seven registered marks to Plaintiff in March of 2019. 17 On April 26, 2016, Defendant registered “MDacne” for “computer software and 18 downloadable computer software for education and advice in the field of care and treatment of 19 skin disorders, namely, acne” in Class 9 (electrical and scientific apparatus) and “providing a 20 website featuring information and advice in the field of the diagnosis and treatment of acne” in 21 Class 41(education and entertainment). This registration claimed first use of May 16, 2010. On 22 July 17, 2018, Defendant registered “MDacne” for “medicated skin treatment and cleansing 23 creams” in Class 5, claiming first use of December 1, 2017, and, subsequently, for “non-medicated 24 skincare preparations” in Class 3. Defendant also registered “MDhair” for “providing temporary 25 1 Including: MD 101, U.S. Reg. 3,459,245; MD LASH FACTOR, U.S. Reg. 3,432,209; MD 26 INTIMATE RESTORE, U.S. Reg. 4,603,019; MD BY SUSAN F. LIN M.D., U.S. Reg. 27 5,860,508; MD INTIMATE FRESH, U.S. Reg. 6,027,099; MD WELLNESS BY SUSAN LIN M.D., U.S. Reg. 6,251,811; and MD FACTOR, U.S. Reg. 6,309,386. 1 use of on-line non-downloadable computer software for education and advice in the field of the 2 case and treatment of skin and hair” in Class 42, claiming first use of September 13, 2010. The 3 USPTO, finding “MDhair” to be descriptive, only permitted registration of this mark on the 4 Supplemental Register. 5 Plaintiff claims that by the time Defendant began offering anything other than software, 6 Plaintiff’s registration of MD for, inter alia, “non-medicated acne treatment preparations” in Class 7 3 and “acne treatment preparations” in Class 5 had been in effect for approximately four years. 8 Plaintiff claims first use of the MD mark as of January 1, 2012. Plaintiff also claims that 9 Defendant has recently expanded beyond software-based systems for which it claims consumer 10 recognition and uses the mark “MDacne” for health and beauty products 11 years after Plaintiff 11 first used its MD-formative mark for similar goods. 12 Defendant denies Plaintiff’s allegations and, instead, avers in its counterclaims that 13 Plaintiff is unlawfully competing with Defendant by purposefully using Defendant’s marks 14 deceptively to lure in Defendant’s customers. By way of example, Defendant points to the fact that 15 Plaintiff took affirmative steps to use the domain 2 to solicit Defendant’s 16 customers who were searching for Defendant’s products despite the fact that Plaintiff does not 17 offer a product called MDHair or MD Hair. In addition, in July 2022, Defendant contends Plaintiff 18 changed the name of its “MD Complexion Factor Acne Cleanser,” product to “MD Acne 19 Complexion Factor Acne Cleanser” after filing the instant suit. In Defendant’s view, that act 20 represents a blatant attempt to deceive Defendant’s potential customers who sought Defendant’s 21 MDacne product. Defendant also argues that Plaintiff may not “monopolize” the term MD for 22 health and cosmetic products as this would be inconsistent with the many instances in which third 23 parties utilize the root “MD” in combination with some other terms. Moreover, Defendant insists 24 that consumer confusion surrounding the “MDacne” and “MDhair” marks is based on Plaintiff’s 25

26 2 For reference, Defendant has been offering its products and services on its website, 27 , since 2021. 1 belated use of those terms, which occurred following Defendant’s use. 2 Defendant further brings counterclaims for cancellation of seven of Plaintiff’s registrations 3 on two grounds: the registrations either are void ab initio or the product of fraud on the USPTO. 4 Specifically, Defendant insists that the registrations for the marks “MD FACTOR,” “MD BY 5 SUSAN F. LIN M.D.,” and “MD WELLNESS BY SUSAN F. LIN M.D.” were all incorrectly 6 filed by Dr. Susan Lin, Plaintiff’s owner and CEO, in her individual capacity in violation of 7 TMEP 1201.02(c) and 37 C.F.R. Section 2.71(d) when, in fact, Plaintiff is the true owner of those 8 marks. This is an incurable defect, per Defendant, rendering the registrations of those marks void 9 ab initio and warranting their cancellation under 15 U.S.C. § 1064. Defendant also maintains that 10 Lin committed fraud on the USPTO and fraudulently derived the right of incontestability with 11 respect to the marks “MD,” “MD INTIMATE RESTORE,” “MD 101,” and “MD LASH 12 FACTOR.” Section 15 of the Lanham Act governs incontestability. Under the statute, an owner 13 must swear, in a declaration, that it has used the mark continuously in commerce for at minimum 14 five years after the date of registration by signing a Section 15 Declaration of Incontestability. 15 15 U.S.C. § 1065. The right of incontestability is “conclusive evidence” of the validity of the mark. 16 15 U.S.C. § 1115.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Foster v. United States
290 F. Supp. 2d 5 (District of Columbia, 2003)
Hokto Kinoko Company v. Concord Farms, Inc.
738 F.3d 1085 (Ninth Circuit, 2013)
Keenan v. Allan
91 F.3d 1275 (Ninth Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
La Canada Ventures, Inc. v. MDalgorithms, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/la-canada-ventures-inc-v-mdalgorithms-inc-cand-2024.